Cox regression model of the effect of HSCT vs chemotherapy on DFS and survival
| Time from first CR* . | Subgroup 2 . | Subgroup 3 . |
|---|---|---|
| HSCT vs chemotherapy on DFS | ||
| At 1 y | 1.54 (0.59-4.03) | 0.89 (0.32-2.46) |
| At 2 y | 0.54 (0.17-1.71) | 0.51 (0.15-1.73) |
| At 3 y | 0.30 (0.06-1.52) | 0.37 (0.08-1.70) |
| At 4 y | 0.19 (0.03-1.48) | 0.29 (0.05-1.74) |
| At 5 y | 0.14 (0.01-1.46) | 0.25 (0.03-1.80) |
| HSCT vs chemotherapy on survival | ||
| At 1 y | 1.27 (0.33-4.95) | 0.53 (0.18-1.60) |
| At 2 y | 0.78 (0.31-1.99) | 0.42 (0.12-1.47) |
| At 3 y | 0.59 (0.18-1.95) | 0.37 (0.07-2.04) |
| At 4 y | 0.48 (0.10-2.22) | 0.34 (0.04-2.74) |
| At 5 y | 0.41 (0.07-2.56) | 0.31 (0.03-3.50) |
| Time from first CR* . | Subgroup 2 . | Subgroup 3 . |
|---|---|---|
| HSCT vs chemotherapy on DFS | ||
| At 1 y | 1.54 (0.59-4.03) | 0.89 (0.32-2.46) |
| At 2 y | 0.54 (0.17-1.71) | 0.51 (0.15-1.73) |
| At 3 y | 0.30 (0.06-1.52) | 0.37 (0.08-1.70) |
| At 4 y | 0.19 (0.03-1.48) | 0.29 (0.05-1.74) |
| At 5 y | 0.14 (0.01-1.46) | 0.25 (0.03-1.80) |
| HSCT vs chemotherapy on survival | ||
| At 1 y | 1.27 (0.33-4.95) | 0.53 (0.18-1.60) |
| At 2 y | 0.78 (0.31-1.99) | 0.42 (0.12-1.47) |
| At 3 y | 0.59 (0.18-1.95) | 0.37 (0.07-2.04) |
| At 4 y | 0.48 (0.10-2.22) | 0.34 (0.04-2.74) |
| At 5 y | 0.41 (0.07-2.56) | 0.31 (0.03-3.50) |
Data are presented as hazard ratio (99% CI).
The Cox model was not applied to subgroup 1 due to the small number of patients transplanted.